[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechPort Avatar @BiotechPort FBCC

FBCC posts on X about $immx, $fulc, $janx, the first the most. They currently have XXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXX% stocks XXXX%

Social topic influence $immx #2, $fulc #18, $janx #18, the first 8.7%, $tern 4.35%, ash 4.35%, will be 4.35%, $vir 4.35%, should be 4.35%, mon XXXX%

Top accounts mentioned or mentioned by @deepsouthdoctor @rezfszubagoly @sanctuarybio @dmitrykovalchuk @bayareabiotechi @monaco_biotech @ciubsandwich070 @sanctuary_bio @plainyogurt21 @ldbioinv

Top assets mentioned Janux Therapeutics, Inc. Common Stock (JANX) Terns Pharmaceuticals, Inc. Common Stock (TERN) Vir Biotechnology, Inc. Common Stock (VIR) AbbVie Inc (ABBV) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Soleno Therapeutics, Inc. Common Stock (SLNO) Kymera Therapeutics, Inc. Common Stock (KYMR) Wave Life Sciences Ltd. Ordinary Shares (WVE)

Top Social Posts

Top posts by engagements in the last XX hours

"$TERN $IMMX Oral presentations at ASH"
X Link 2025-11-03T14:15Z 3620 followers, 3438 engagements

"$JANX I got a feeling this will be a significant data set. Positive data should be a good readthrough to $VIR which I think is at negative EV as of now"
X Link 2025-11-14T16:53Z 3621 followers, 26.4K engagements

"@DmitryKovalchuk $JANX The data looks very decent in my view and more. The reason for the drop is their very poor job on the PR"
X Link 2025-12-01T21:59Z 3621 followers, 1929 engagements

"@BayAreaBiotechI $FULC Good luck to Bears on Mon"
X Link 2025-12-07T00:20Z 3621 followers, XXX engagements

"@rezfszubagoly Not following that name close enough to give a decent answer"
X Link 2025-12-07T18:44Z 3621 followers, XXX engagements

"@Sanctuary_Bio $IMMX still looks better to me. Bispecific needs XX cycles monthly injections. Also it is not clear to me if AbbVie is pushing for approval in rr AL. Will be interesting to compare the safety"
X Link 2025-12-08T00:20Z 3621 followers, 1022 engagements

"$FULC Objectively best case data in my view. Drug with exiting potential in SCD"
X Link 2025-12-06T23:36Z 3619 followers, 2376 engagements

"$RYTM $SLNO PWS data before Christmas. Sounds to me on the call that $RYTM hedging the expectations for this read out"
X Link 2025-11-04T13:08Z 3621 followers, 6151 engagements

"$FULC Money slide"
X Link 2025-12-07T16:11Z 3619 followers, 4307 engagements

"$IMMX It is possible we are seeing emergence of a functional cure for this nasty sever disease. Sure first it will go for the r/r patients but whoever will buy them out can move to the first. Patients can be cure directly after the diagnosis without the need of taking chronic drugs for years and preventing any continuation of slow deterioration of the organs. Also just secured a nice pipe. Supper cheap here. $150MM EV"
X Link 2025-12-07T23:28Z 3620 followers, 5376 engagements

"@Sanctuary_Bio The bispecifics are half of the efficacy (till now at least) nasty safety profile and chronic treatment. I am not sure anyone is seriously developing bispecifics in this indication. $IMMX should be approved next year"
X Link 2025-12-07T23:44Z 3620 followers, 1158 engagements

"$IMMX "One and done treatment" according to the KOL. CRS Gr 1-2 (majority Gr1) 1d duration. No Neurological side effects. Some patients are in CR more than 12m The X in VGPR are on their way to get to CRs according to the KOL. Amazing If this get to the first line this is a potential functional cure for the majority of AL Amyloidosis patients. No need for chronic treatment less side effects and no slow deterioration of the organs"
X Link 2025-12-08T01:50Z 3620 followers, 5020 engagements

"$KYMR is a $9B company with open label non controlled Ph1b data"
X Link 2025-12-08T15:07Z 3620 followers, 9817 engagements

"$WVE I am happy it is running. Let the Bulls run. Good for everyone. But no one explained me as of now how is a drug that reduces more fat in % than GLP-1 at 12w and had roughly the same lean mass effect as placebo did not reduce the total weight vs. placebo (actually I think it increased weight vs. placebo). "Muscle is more dense" does not explain it. First the difference in dancetty is XX% only and second placebo had very similar effect on muscle as the drug"
X Link 2025-12-08T23:17Z 3620 followers, 9932 engagements